Demant, DK0010268440

Demant stock gains as Oddo raises price target to 275 DKK

Published on 09/18/2026 at 20:23 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS

Demant stock closed at DKK 299.20 on Nasdaq Copenhagen on September 17, 2026, near fresh 52-week highs. Oddo raised its price target to DKK 275 from DKK 260 on September 18, 2026, while keeping a neutral rating on the shares.

Fotorealistische Szene einer Hörgeräte-Fertigung in modernem Reinraum, Medizintechnik-Industrie
Fotorealistisches Bild zeigt Demant A/S, ISIN DK0010268440, mit Hörgeräte-Fertigung und modernem Reinraum in Dänemark, Illustration mit AI erstellt.

Demant stock (ISIN DK0010268440) closed at DKK 299.20 on Nasdaq Copenhagen on September 17, 2026, putting the hearing-care group close to a fresh 52-week high as investors digested a new analyst target.MarketScreener reported on September 18, 2026 that Oddo lifted its price target for Demant to DKK 275 from DKK 260, while reiterating a neutral stance.

Oddo target hike and valuation context

According to MarketScreener on September 18, 2026, Oddo raised its price target for Demant to DKK 275 from a previous DKK 260 and maintained a neutral rating, signaling that the broker sees limited upside from current levels despite the company’s strong share performance year to date. With Demant’s last closing price at DKK 299.20 on September 17, 2026, the new Oddo target now stands DKK 24.20 below the market price, implying a discount of roughly 8.1 percent compared with where the stock is trading. The same overview shows a consensus target of DKK 302.55, only DKK 3.35 above the latest close, underlining that the broader analyst community also sees the shares as fairly valued near current levels.

As MarketScreener details, Demant shares have gained 39.03 percent since the start of 2026 and 1.98 percent over the past five trading days as of the close on September 17, 2026, reflecting robust investor confidence in the company’s strategy and earnings trajectory. For investors, the key takeaway from Oddo’s move is that the broker has acknowledged the improved fundamental picture by increasing the target by 5.8 percent from DKK 260 to DKK 275, but the neutral rating and the target below the current price underscore a more cautious stance on further short-term upside.

Stock brushes 52-week high in Copenhagen

Demant’s strong run has recently pushed the shares to fresh 52-week highs. According to Investing.com in a Denmark market wrap dated September 18, 2026, Demant A/S shares rose 0.60 percent or DKK 1.80 in late trade to reach DKK 301.00 and were noted as having climbed to 52-week highs. This puts the latest trading level slightly above the prior close of DKK 299.20 from September 17, 2026 and highlights the momentum behind the stock as it trades near its recent peak. The move came even as the OMX Copenhagen 20 index slipped 0.32 percent, suggesting that Demant outperformed the broader Danish market on that trading day.

Per the same Investing.com report on September 18, 2026, Demant added DKK 1.80 on the day, taking its share price to DKK 301.00 and reinforcing the picture of a stock that is benefitting from sector-specific tailwinds in hearing care and audiology solutions. For shareholders, the fact that Demant reached a 52-week high while the OMX Copenhagen 20 index declined underlines how company-specific drivers, including recent earnings and guidance, are dominating the share price rather than broader market sentiment.

What the recent rally means for investors

The combination of a near-consensus valuation and strong price performance leaves Demant in an interesting position for investors as of September 18, 2026. On the one hand, the 39.03 percent year-to-date gain reported by MarketScreener shows that the market has already priced in a substantial improvement in Demant’s operating performance, including better profitability and a strong order pipeline. On the other hand, the relatively tight gap between the consensus target of DKK 302.55 and the latest close at DKK 299.20 suggests limited expected upside from current levels according to analysts, which may temper expectations for further rapid gains without new positive surprises in upcoming quarters.

Risk-wise, the neutral stance reiterated by Oddo on September 18, 2026 points to potential challenges that could cap further valuation expansion, such as competitive pressures in hearing aids and diagnostics, currency fluctuations affecting reported results, and the need for continued innovation to maintain market share. While the specific risk factors were not detailed in the short analyst note summarized by MarketScreener, the decision to keep a neutral rating even after raising the target indicates that Oddo sees a balance between the company’s solid fundamentals and valuation constraints at current prices.

Demant price snapshot and trading venue

As of the most recent completed trading day on Nasdaq Copenhagen, September 17, 2026, Demant stock closed at DKK 299.20, with the subsequent move to DKK 301.00 on September 18, 2026 representing a day gain of 0.60 percent or DKK 1.80 in late trade per Investing.com. The shares are listed on Nasdaq Copenhagen under the ticker DEMANT, and the recent prices place the stock very close to the average analyst price target of DKK 302.55 reported by MarketScreener on September 18, 2026.

Key data on Demant stock

  • Company: Demant A/S
  • ISIN: DK0010268440
  • Ticker: DEMANT
  • Trading venue: Nasdaq Copenhagen
  • Price (as of September 18, 2026): 301.00 DKK
  • Sector / Industry: Health care equipment and services
  • Index membership: OMX Copenhagen 20

More news and analyses on Demant stock

Disclaimer...

en | DK0010268440 | DEMANT | boerse | 70127768 | bgmi